Chemistry:BK-5-MAPBT

From HandWiki

BK-5-MAPBT, also known as β-keto-5-MAPBT, is a possible entactogen of the benzothiophene and cathinone families.[1] It is a potent monoamine releasing agent, including of serotonin and dopamine, and also acts as a potent serotonin 5-HT1B receptor agonist.[1] Conversely, norepinephrine release was not reported.[1] Unlike non-cathinone benzothiophenes like 5-MAPBT and 6-MAPBT, BK-5-MAPBT is very weak or inactive as a serotonin 5-HT2B receptor antagonist and monoamine oxidase A (MAO-A) inhibitor.[1] It produces anxiolytic-like and antiobsessional-like effects in the marble burying test in rodents.[1] BK-5-MAPBT has been studied and patented by Matthew J. Baggott of Tactogen.[1]

See also

References

  1. 1.0 1.1 1.2 1.3 1.4 1.5 Baggott M, "Advantageous benzothiophene compositions for mental disorders or enhancement", WO patent 2022010937A1, published 13 January 2022